FDA Seeks Comment on Labeling Update Pilot

Generic Line
The FDA is seeking stakeholder feedback on a proposed initiative that would encourage drugmakers to use an updated drug labeling format even if they are not legally required to do so.

To View This Article:


Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00